Request Deal Involvement

Jenssen Biotech acquired BeneVir Biopharma from HC2 for up to $1.04bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Hogan Lovells

legal advisors

Hogan Lovells

or

Principals

HC2 HOLDINGS INC

vendor

HC2 HOLDINGS INC

JANSSEN BIOTECH INC

bidder

JANSSEN BIOTECH INC

BENEVIR BIOPHARM INC

target

BENEVIR BIOPHARM INC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Jenssen Biotech acquired BeneVir Biopharma from HC2 for up to $1.04bn.